1. Home
  2. TBPH vs ORRF Comparison

TBPH vs ORRF Comparison

Compare TBPH & ORRF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TBPH
  • ORRF
  • Stock Information
  • Founded
  • TBPH 2013
  • ORRF 1919
  • Country
  • TBPH United States
  • ORRF United States
  • Employees
  • TBPH N/A
  • ORRF N/A
  • Industry
  • TBPH Biotechnology: Pharmaceutical Preparations
  • ORRF Major Banks
  • Sector
  • TBPH Health Care
  • ORRF Finance
  • Exchange
  • TBPH Nasdaq
  • ORRF Nasdaq
  • Market Cap
  • TBPH 699.0M
  • ORRF 674.4M
  • IPO Year
  • TBPH N/A
  • ORRF N/A
  • Fundamental
  • Price
  • TBPH $14.58
  • ORRF $33.93
  • Analyst Decision
  • TBPH Strong Buy
  • ORRF Buy
  • Analyst Count
  • TBPH 4
  • ORRF 2
  • Target Price
  • TBPH $23.00
  • ORRF $42.00
  • AVG Volume (30 Days)
  • TBPH 367.5K
  • ORRF 102.7K
  • Earning Date
  • TBPH 11-11-2025
  • ORRF 10-21-2025
  • Dividend Yield
  • TBPH N/A
  • ORRF 3.19%
  • EPS Growth
  • TBPH N/A
  • ORRF N/A
  • EPS
  • TBPH 0.26
  • ORRF 2.24
  • Revenue
  • TBPH $77,205,000.00
  • ORRF $233,724,000.00
  • Revenue This Year
  • TBPH $79.82
  • ORRF $30.74
  • Revenue Next Year
  • TBPH N/A
  • ORRF N/A
  • P/E Ratio
  • TBPH $56.32
  • ORRF $15.12
  • Revenue Growth
  • TBPH 24.49
  • ORRF 80.10
  • 52 Week Low
  • TBPH $7.88
  • ORRF $25.57
  • 52 Week High
  • TBPH $15.15
  • ORRF $41.99
  • Technical
  • Relative Strength Index (RSI)
  • TBPH 60.51
  • ORRF 44.05
  • Support Level
  • TBPH $14.00
  • ORRF $33.14
  • Resistance Level
  • TBPH $14.87
  • ORRF $34.93
  • Average True Range (ATR)
  • TBPH 0.50
  • ORRF 0.86
  • MACD
  • TBPH -0.02
  • ORRF -0.19
  • Stochastic Oscillator
  • TBPH 62.00
  • ORRF 28.73

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

About ORRF Orrstown Financial Services Inc

Orrstown Financial Services Inc is a holding company engaged in commercial banking and trust business, this involves accepting demand, time, and savings deposits and granting loans. The company is also engaged in lending services for commercial, residential, commercial mortgages, construction, municipal, and various forms of consumer lending, and deposit services that include checking, savings, time, and money market deposits. It also provides investment and brokerage services through its Financial Advisors division. The Company earns fees from its deposit clients for transaction-based account maintenance and overdraft services, It also earns wealth management and investment brokerage fees from its contracts with trusts. The company operates in a segment, namely Community Banking.

Share on Social Networks: